Niagen Bioscience, Inc.

Niagen Bioscience Inc. is a global bioscience company recognized for pioneering research and commercialization of NAD+—nicotinamide adenine dinucleotide—science, a vital coenzyme essential for cellular energy production, healthy aging, and metabolic homeostasis. Formed in 1999 and headquartered in Los Angeles, California, the company operates through three primary business segments: consumer products, proprietary ingredients, and analytical reference standards and services. Its flagship ingredient, Niagen (nicotinamide riboside), is backed by a robust patent portfolio and extensive clinical research, and serves as the foundation for a suite of evidence-based supplements and pharmaceutical solutions designed to optimize NAD+ levels and promote cellular health. Niagen Bioscience Inc. differentiates itself through rigorous scientific standards, ISO-accredited laboratories, and collaborations with leading global research institutions, underscoring its commitment to quality and innovation. As awareness of NAD+’s role in aging and wellness grows, the company stands at the forefront of a rapidly expanding market for healthy aging products, providing both end-consumer supplements and raw materials for specialized industries.